Hyperlipidemic nephropathy induced by adriamycin in ovariectomized rats: Role of free radicals and effect of 17-beta-estradiol administration

Nephron

Volumn 85, Issue 1, 2000, Pages 65-70

  Montilla, P ^a   Tunez I ^b   Munoz M C ^b   Delgado, M J ^b   Salcedo, M ^b  

^a Universidad de Cordoba   (Spain)

^b NONE

Author keywords

Adriamycin; Estrogens; Free radicals; Nephropathy; Ovariectomy

Indexed keywords

CREATININE; DOXORUBICIN; ESTRADIOL; FREE RADICAL; GLUTATHIONE; LIPID; MALONALDEHYDE; NITROGEN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HYPERLIPIDEMIA; KIDNEY DISEASE; LIPID BLOOD LEVEL; LIPID PEROXIDATION; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; UREA NITROGEN BLOOD LEVEL;

EID: 0034104133     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045632     Document Type: Article

References (49)

1. Hannedouche T, Chauveau P, Kalou F, Albouza G, Lacour B: Factor affecting progression in advanced chronic renal failure. Clin Nephrol 1993;39:312-320.
2. Silbiger S, Neugarten J: The impact of gender on progressive renal functional impairment. Am J Kidney Dis 1995;25:515-533.
3. Rosman JB, Langer K, Brandl M, Piers-Becht TP, van der Henn GK, ter Wee PM, Donker AJ: Protein-restricted diets in chronic renal failure: A four-year follow-up shows limited indications. Kidney Int 1989;36:(suppl 27):96-102.
4. Seller AL, Goodman HC, Marmorston J, Smith M: Sex difference in proteinuria in the rat. Am J Physiol 1950;163:662-667.
5. Remuzzi A, Puntorieri S, Mazzoleni A, Remuzzi G: Sex related differences in glomerular ultrafiltration and proteinuria in Munich-Wistar rats. Kidney Int 1988;34:481-486.
6. Weening J, Rennke H: Glomerular permeability and polyanion adriamycin nephrosis in the rat. Kidney Int 1983;24:152-159.
7. Bertani T, Cutillo F, Zoja C, Broggini M, Remuzzi G: Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 1986;30:488-496.
8. Bertani T, Rochi G, Mecca R, Remuzzi G: Adriamycin-induced glomerulosclerosis in the rat. Am J Kidney Dis 1988;7:12-19.
9. Okuda S, Oh Y, Tsuruda H, Onoyuma K, Fujimi S, Fujishima M: Adriamycin-induced nephropathy as a model of chronic progressive glomerular disese. Kidney Int 1986;29:502-510.
10. Mukai K, Daifuku K, Yokoyama S, Nakama M: Stopped-flox investigation of antioxidant activity of estrogens in solution. Biochim Biophys Acta 1990;1035:348-355.
11. Rifici VA, Khachadurian AK: The inhibition of low-density lipoprotein oxidation by 17β-estradiol. Metabolism 1992;41:1110-1114.
12. Sugioka K, Shimosegawa Y, Nakano M: Estrogens as natural antioxidants of membrane phospholipid peroxidations. FEBS Lett 1987; 210:37-39.
13. Subbiah MTR, Kessel B, Agrawal M, Rajan R, Abplanalp W, Rymaszewski Z: Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metab 1993;77: 1095-1098.
14. Ayres S, Tang M, Subbiah MTR: Estradiol-17β as an antioxidant: Some distinct features when compared with common fat-soluble antioxidants. J Lab Clin Med 1996;128:367-375.
15. Poumeau-Delille G: Techniques biologiques en endocrinologie expérimentale chez le rat. Paris, 1953, Masson.
16. Beutler EB: Red Cell Metabolism: A Manual of Biochemical Methods, ed 3. Orlando, Grune & Stratton, 1984, pp 105-106.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurements with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
18. van Kampen EJ, Zijlstra WG: Standardization of hemoglobinometry. II. The hemoglobincyanide methods. Clin Chem Acta 1961;6: 538-545.
19. Suzuki Y, Ohnuma T, Goldsmith MA: Nephrotoxic effects of adriamycin in rabbits. Fed Proc 1978;37:320.
20. Fajardo LF, Eltthringham J, Stewart J, Kaluber M: Adriamycin nephrotoxicity. Lab Invest 1980;43:242-253.
21. Bertani T, Poggi A, Pozzoni R, Delaini F, Sacchi G, Thoua Y, Mecca G, Remuzzi G, Donatti MB: Adriamycin induced nephrotic syndrome in rats: Sequence pathologic events. Lab Invest 1982;46:16-23.
22. Canepa A, Ghiggeri GM, Ginevri F, Trivelli A, Perfumo F, Gusmano R: Modulation of proteinuria and renal xanthine oxidase activity by dietary proteins in acute adriamycin nephrosis in rats: Lack of correlation with intra-and extracellular amino acids. Nephron 1992;60: 342-348.
23. Ichikawa I, Kimaya S, Yoshioka T: Rend antioxidant enzymes: Their regulation and function. Kidney Int 1994;45:1-9.
24. Washio M, Nanishi F, Okuda S, Onoyama K, Fujishima M: Alpha tocopherol improves focal glomerulosclerosis in rats with adriamycin-induced progressive renal failure. Nephron 1994; 68:347-352.
25. Okasora T, TakikawaT, Utsunomiya Y, Senoh I, Hayashibara H, Shiraki K, Kasagi T, Shimizu F: Suppressive effect of Superoxide dismutase on adriamycin nephropathy. Nephron 1992;60:199-203.
26. Montilla P, Túnez I, Muñoz MC, López A, Soria JV: Hyperlipidemic nephropathy induced by adriamycin: Effect of melatonin administration. Nephron 1997;76:345-350.
27. Haffener SM, Valder RA: Endogenous sex hormone: Impact on lipid, lipoproteins and insulin. Am J Med 1995;98:405-475.
28. Haarbo J, Christiansen C: The impact of female sex hormone on secundary prevention of atherosclerosis in ovariectomized cholesterol-fed rabbits. Atherosclerosis 1996;123:139-144.
29. Huber LA, Scheffler E, Poll T, Ziegler R, Dresel HA: 17-Beta-estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages. Free Radic Res Commun 1990; 8:167-173.
30. Imai Y, Marsumura H, Miyajima H, Okada K: Serum and tissue lipids and glomerulonephritis in the spontaneously hypercholesterolemic (SNC) rat, with a note on gonadectomy. Atherosclerosis 1977;27:165-178.
31. Takanobu S, Noriaki O, Yoshiyuki S, Fumitaka M: Effect of ovariectomy on glomerular injury in hypercholesterolemic female Imai rats. Nephron 1996;72:72-78.
32. El Hahas M, Bassetta AH, Cope GH, Carpentier JE: Role of growth hormone in the development of experimental renal scarring. Kidney Int 1991;20:29-34.
33. Goya RG, Castelletto L, Sosa YE: Plasma levels of growth hormone correlate with the severity of pathologic changes in the renal structure of aging rats. Lab Invest 1991;64:29-34.
34. Jansson JO, Ekberg S, Isaksson OGP, Eden S: Influence of gonadal steroids in age- and sex-related secretory patterns of growth in the rat. Endocrinology 1984;114:1287-1294.
35. Sakemi T, Noriaki O, Yoshiyuki S, Fumitaka M: Ovariectomy attenuates proteinuria and glomerular injury in unilaterally nephrectomized female Sprague-Dawley rats. Nephron 1996;73:251-257.
36. Sakemi T, Noriaki O, Yoshiyuki T, Fumitaka M: Attenuating effect of castration on glomerular injury is age-dependent in unilaterally nephrectomized male Sprague-Dawley rats. Nephron 1997;75:347-349.
37. Link K, Blizzard RM, Evans WS, Kaiser DL, Parker MW, Rogol AD: The effect of androgens on true pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males. J Clin Endocrinol Metab 1986;62:159-164.
38. Noriaki O, Takanobu S, Yoshiyuki T, Fumitaka M: Different effect of estrogen administration from castration on glomerular injury in unilaterally nephrectomized male Sprague-Dawley rats. Nephron 1997;77:444-451.
39. Joles JA, Biljeveld C, van Tol A, Geelen MJH, Koomans HA: Estradiol fails to reduce LDL cholesterol and fibrinogen and exacerbates hypertriglyceridemia in ovariectomized nephrotic rats (abstract). J Am Soc Nephrol 1996;7: 618.
40. Joles JA, Bilijeveld C, van Tol A, Geelen MJH, Koomans HA: Ovariectomy decreases plasma triglycerides levels in analbuminemic rats by lowering hepatic triglyceride secretion. Atherosclerosis 1995;117:51-59.
41. Joles JA, van Goor H, van Der Horst ML, van Tol A. Weening JJ, Koomans HA: Ovariectomy decreases plasma triglycerides levels and both prevents and alleviates glomerular disease in uninephrectomized female analbuminemic rats. J Am Soc Nephrol 1996;7:1189-1197.
42. Gades M, Stern J, van Door H, Nguyen D, Johnson P, Kaysen G: Estrogen accelerates the development of renal disease in female obese Zucker rats. Kidney Int 1998;53:130-135.
43. Steiner G: The dyslipoproteinemias of diabetes. Atherosclerosis 1994;110:27-33.
44. Negre-Salvayre A, Pieraggi M-T, Mabile L, Salvayre R: Protective effect of 17β-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis 1993;99:207-217.
45. Neugarten J, Chossein C, Silbiger S: Estradiol inhibits mesangial cell-mediated oxidation of low density lipoprotein. J Lab Clin Med 1995; 126:385-391.
46. Suzukawa M, Ishikawa T, Yoshida H, Nakamura H: Effect of in vivo supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification. J Am Coll Nutr 1995;14:46-52.
47. Jialal I, Deveraj S: Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: A clinical biochemistry perspective. Clin Chem 1996;42:498-506.
48. Neugarten J, Silbiger SR: Effects of sex hormones on mesangial cells. Am J Kidney Dis 1995;26:147-151.
49. Martín C, Barturen K, Martínez R, Lacort M, Ruíz-Larrea MB: In vitro inhibition by estrogens of the oxidative modifications of human lipoproteins. J Physiol Biochem 1998;54:195-202.